疫苗安全科学:惠康基金会会议摘要
2019年5月在伦敦惠康基金会召开会议,约30名专家评估疫苗安全科学现状,回顾全球不同地区情况、接种后特定疾病发生率与疫苗成分安全性等争议领域,并讨论人乳头瘤病毒疫苗安全性受质疑的问题,明确已知证据与需进一步研究的领域。
要点
- 疫苗广泛成功但面临不安全认知的质疑,疫苗安全性须持续科学研究。
- 会议评估疫苗安全已知证据与需额外研究的领域,涵盖接种后特定疾病发生率及疫苗成分安全性。
- 人乳头瘤病毒疫苗安全性受反对者特别质疑,会议将其纳入讨论。
核心结论
- 会议评估了疫苗安全领域已知超越合理怀疑的证据以及需要额外研究的领域,但摘要未给出具体结论。
研究设计与样本
- 2019年5月在伦敦惠康基金会召开会议,约30名专家参加,回顾全球不同地区疫苗安全现状及特定争议领域。
主要发现
- 会议回顾了全球不同地区疫苗安全现状、接种后特定疾病发生率及特定疫苗成分安全性,并讨论了人乳头瘤病毒疫苗安全性受质疑的问题。
临床怎么用
- 原文未据此给出推荐。
局限性
- 会议未能覆盖疫苗安全科学的所有方面。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vaccines are everywhere hugely successful but are also under attack. The reason for the latter is the perception by some people that vaccines are unsafe. However that may be, vaccine safety, life any other scientific subject, must be constantly studied. It was from this point of view that a meeting was organized at the Wellcome Trust in London in May 2019 to assess some aspects of vaccine safety as subjects for scientific study. The objective of the meeting was to assess what is known beyond reasonable doubt and conversely what areas need additional studies. Although the meeting could not cover all aspects of vaccine safety science, many of the most important issues were addressed by a group of about 30 experts to determine what is already known and what additional studies are merited to assess the safety of the vaccines currently in use. The meeting began with reviews of the current situation in different parts of the world, followed by reviews of specific controversial areas, including the incidence of certain conditions after vaccination and the safety of certain vaccine components. Lastly, information about the human papillomavirus vaccine was considered because its safety has been particularly challenged by vaccine opponents. The following is a summary of the meeting findings. In addition to this summary, the meeting organizers will explore opportunities to perform studies that would enlarge knowledge of vaccine safety.
引用
- Plotkin SA, Offit PA, DeStefano F, et al. The science of vaccine safety: Summary of meeting at Wellcome Trust. Vaccine. 2020. PMID: 31987690. doi:10.1016/j.vaccine.2020.01.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。